Uveitis Associated with Juvenile Idiopathic Arthritis

References

• Edelsten C, Reddy MA, Stanford MR, Graham EM. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135(5):676–680. doi:10.1016/S0002-9394(02)02148-7.
   PubMed Web of Science ®Google Scholar
• de Boer J, Wulffraat N, Rothova Br AJ. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87(7):879–884. doi:10.1136/bjo.87.7.879.
   PubMed Web of Science ®Google Scholar
• Hettinga YM, de Groot-Mijnes JDF, Rothova A, de Boer JH. Infectious involvement in a tertiary center pediatric uveitis cohort. Br J Ophthalmol. 2015;99(1):103–107. doi:10.1136/bjophthalmol-2014-305367.
   PubMed Web of Science ®Google Scholar
• Hayworth JL, Turk MA, Nevskaya T, Pope JE. The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases. Joint Bone Spine. 2019;86(6):685–690. doi:10.1016/j.jbspin.2019.06.001.
   PubMed Web of Science ®Google Scholar
• Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Clin Immunol. 2020;211:108322. doi:10.1016/j.clim.2019.108322.
   PubMed Web of Science ®Google Scholar
• van Straalen JW, Giancane G, Amazrhar Y, et al. A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis. Rheumatology. 2021;60(6):2896–2905. doi:10.1093/rheumatology/keaa733.
   PubMed Web of Science ®Google Scholar
• van Straalen JW, van Stigt Thans M, Wulffraat NM, de Roock S, Swart JF. A diagnostic prediction model for separating juvenile idiopathic arthritis and chronic musculoskeletal pain syndrome. J Pediatr. 2022;251:164–171.e6. doi:10.1016/j.jpeds.2022.04.029.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Klotsche J, Sengler C, et al. Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis. Arthritis Rheumatol. 2018;70(10):1685–1694. doi:10.1002/art.40544.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology. 2007;46(6):1015–1019. doi:10.1093/rheumatology/kem053.
   PubMed Web of Science ®Google Scholar
• Sen ES, Dick AD, Ramanan AV. Uveitis associated with juvenile idiopathic arthritis. Nat Rev Rheumatol. 2015;11(6):338–348. doi:10.1038/nrrheum.2015.20.
   PubMed Web of Science ®Google Scholar
• Vitale AT, Graham E, de Boer JH. Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Ocul Immunol Inflamm. 2013;21(6):478–485. doi:10.3109/09273948.2013.815785.
   PubMed Web of Science ®Google Scholar
• Clarke SLN, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol. 2016;14(1):27. doi:10.1186/s12969-016-0088-2.
   PubMed Web of Science ®Google Scholar
• Chia A, Lee V, Graham EM, Edelsten C. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;135(6):757–762. doi:10.1016/S0002-9394(03)00225-3.
   PubMed Web of Science ®Google Scholar
• Angeles‐Han ST, Ringold S, Beukelman T, et al. 2019 American college of rheumatology/arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis–associated uveitis. Arthritis Care Res (Hoboken). 2019;71(6):703–716. doi:10.1002/acr.23871.
   PubMed Web of Science ®Google Scholar
• Haasnoot A-MJW, Kuiper JJW, de Boer JH. Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice. Expert Rev Clin Immunol. 2019;15(6):657–666. doi:10.1080/1744666X.2019.1593139.
   PubMed Web of Science ®Google Scholar
• Vastert SJ, Bhat P, Goldstein DA. Pathophysiology of JIA-associated uveitis. Ocul Immunol Inflamm. 2014;22(5):414–423. doi:10.3109/09273948.2014.926937.
   PubMed Web of Science ®Google Scholar
• Walscheid K, Neekamp L, Heiligenhaus A, et al. Increased circulating proinflammatory T lymphocytes in children with different forms of anterior uveitis: results from a pilot study. Ocul Immunol Inflamm. 2019;27(5):788–797. doi:10.1080/09273948.2018.1467464.
   PubMed Web of Science ®Google Scholar
• Walscheid K, Neekamp L, Heiligenhaus A, et al. Peripheral blood monocytes reveal an activated phenotype in pediatric uveitis. Clin Immunol. 2018;190:84–88. doi:10.1016/j.clim.2017.09.014.
   PubMed Web of Science ®Google Scholar
• Kalinina Ayuso V, van Dijk MR, de Boer JH. Infiltration of plasma cells in the iris of children with ANA-positive anterior uveitis. Invest Ophthalmol Vis Sci. 2015;56(11):6770–6778. doi:10.1167/iovs.15-17351.
   PubMed Web of Science ®Google Scholar
• Kalinina Ayuso V, Makhotkina N, van Tent-Hoeve M, et al. Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown. Surv Ophthalmol. 2014;59(5):517–531. doi:10.1016/j.survophthal.2014.03.002.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology (Oxford). 2011;50(8):1390–1394. doi:10.1093/rheumatology/ker107.
   PubMed Web of Science ®Google Scholar
• Wennink RAW, Pandit A, Haasnoot A-MJW, et al. Whole transcriptome analysis reveals heterogeneity in B cell memory populations in patients with juvenile idiopathic arthritis-associated uveitis. Front Immunol. 2020;11:2170. doi:10.3389/fimmu.2020.02170.
   PubMed Web of Science ®Google Scholar
• Wildschütz L, Ackermann D, Witten A, et al. Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis. J Autoimmun. 2019;100:75–83. doi:10.1016/j.jaut.2019.03.004.
   PubMed Web of Science ®Google Scholar
• Haasnoot A-MJW, Schilham MW, Kamphuis S, et al. Identification of an amino acid motif in HLA – DR β1 that distinguishes uveitis in patients with juvenile idiopathic arthritis. Arthritis Rheumatol. 2018;70(7):1155–1165. doi:10.1002/art.40484.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, McCracken C, Yeh S, et al. HLA associations in a cohort of children with juvenile idiopathic arthritis with and without uveitis. Invest Ophthalmol Vis Sci. 2015;56(10):6043–6048. doi:10.1167/iovs.15-17168.
   PubMed Web of Science ®Google Scholar
• Wennink RAW, de Boer JH, Hiddingh S, et al. Next-generation HLA sequence analysis uncovers shared risk alleles between clinically distinct forms of childhood uveitis. Invest Ophthalmol Vis Sci. 2021;62(9):19. doi:10.1167/iovs.62.9.19.
   PubMed Web of Science ®Google Scholar
• Murray KJ, Szer W, Grom AA, et al. Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset juvenile rheumatoid arthritis and iridocyclitis: selective association with MHC gene. J Rheumatol. 1997;24(3):560–567.
   PubMed Web of Science ®Google Scholar
• Neuteboom GH, Hertzberger-ten Cate R, de Jong J, van den Brink HG, Feltkamp TE. Antibodies to a 15 kD nuclear antigen in patients with juvenile chronic arthritis and uveitis. Invest Ophthalmol Vis Sci. 1992;33:1657–1660.
   PubMed Web of Science ®Google Scholar
• Walscheid K, Hennig M, Heinz C, et al. Correlation between disease severity and presence of ocular autoantibodies in juvenile idiopathic arthritis-associated uveitis. Invest Ophthalmol Vis Sci. 2014;55(6):3447–3453. doi:10.1167/iovs.13-13444.
   PubMed Web of Science ®Google Scholar
• Walscheid K, Heiligenhaus A, Holzinger D, et al. Elevated S100A8/A9 and S100A12 serum levels reflect intraocular inflammation in juvenile idiopathic arthritis-associated uveitis: results from a pilot study. Invest Ophthalmol Vis Sci. 2015;56(13):7653–7660. doi:10.1167/iovs.15-17066.
   PubMed Web of Science ®Google Scholar
• van den Broek T, Hoppenreijs E, Meerding J, et al. Cytokine profiling at disease onset: support for classification of young antinuclear antibody-positive patients as a separate category of juvenile idiopathic arthritis. Ann Rheum Dis. 2015;74(2):470–472. doi:10.1136/annrheumdis-2014-206424.
   PubMed Web of Science ®Google Scholar
• Haasnoot AJW, van Tent-Hoeve M, Wulffraat NM, et al. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis. Am J Ophthalmol. 2015;159(2):372–7.e1. doi:10.1016/j.ajo.2014.11.007.
   PubMed Web of Science ®Google Scholar
• Bou R, Adán A, Borrás F, et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int. 2015;35(5):777–785. doi:10.1007/s00296-015-3231-3.
   PubMed Web of Science ®Google Scholar
• Leverette TJ. Key terms for contracts with grocery firms. Hospitals (Lond). 1980;54:86–91.
   Google Scholar
• Wennink RAW, Kalinina Ayuso V, Pameijer EM, et al. Improved clinical outcomes in patients with juvenile idiopathic arthritis associated uveitis in the last decade. Acta Ophthalmol. 2022;100(7):781–787. doi:10.1111/aos.15097.
   PubMed Web of Science ®Google Scholar
• Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in Resistant Juvenile Rheumatoid Arthritis. N Engl J Med. 1992;326(16):1043–1049. doi:10.1056/NEJM199204163261602.
   PubMed Web of Science ®Google Scholar
• Ruperto N, Murray KJ, Gerloni V, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. 2004;50(7):2191–2201. doi:10.1002/art.20288.
   PubMed Web of Science ®Google Scholar
• Reiff A, Shaham B, Wood BP, et al. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1995;13(1):113–118.
   PubMed Web of Science ®Google Scholar
• Shea B, Swinden MV, Ghogomu ET, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. J Rheumatol. 2014;41(6):1049–1060. doi:10.3899/jrheum.130738.
   PubMed Web of Science ®Google Scholar
• Simonini G, Paudyal P, Jones GT, Cimaz R, Macfarlane GJ. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology. 2013;52(5):825–831. doi:10.1093/rheumatology/kes186.
   PubMed Web of Science ®Google Scholar
• Ferrara G, Mastrangelo G, Barone P, et al. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatr Rheumatol. 2018;16(1):46. doi:10.1186/s12969-018-0255-8.
   PubMed Web of Science ®Google Scholar
• Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M. Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol. 2007;91(2):180–184. doi:10.1136/bjo.2006.094698.
   PubMed Web of Science ®Google Scholar
• Goebel JC, Roesel M, Heinz C, et al. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. Br J Ophthalmol. 2011;95(2):209–213. doi:10.1136/bjo.2009.173542.
   PubMed Web of Science ®Google Scholar
• Chen JL, Abiri P, Tsui E. Recent advances in the treatment of juvenile idiopathic arthritis-associated uveitis. Ther Adv Ophthalmol. 2021;13:2515841420984572. doi:10.1177/2515841420984572.
   Web of Science ®Google Scholar
• Quartier P, Baptiste A, Despert V, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis. 2018;77(7):1003–1011. doi:10.1136/annrheumdis-2017-212089.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Benton D, et al. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE trial). Trials. 2014;15(1):14. doi:10.1186/1745-6215-15-14.
   PubMedGoogle Scholar
• Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT. Current evidence of anti–tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs. Arthritis Care Res. 2014;66(7):1073–1084. Preprint at. doi:10.1002/acr.22214.
   PubMed Web of Science ®Google Scholar
• Simonini G, Katie D, Cimaz R, Macfarlane GJ, Jones GT. Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach. Semin Arthritis Rheum. 2014;44(1):39–46. doi:10.1016/j.semarthrit.2014.03.001.
   PubMed Web of Science ®Google Scholar
• Leinonen ST, Aalto K, Kotaniemi KM, Kivelä TT. Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis. Clin Exp Rheumatol. 2017;35:1043–1046.
   PubMed Web of Science ®Google Scholar
• Schmeling H. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study. Ann Rheum Dis. 2001;60(4):410–412. doi:10.1136/ard.60.4.410.
   PubMed Web of Science ®Google Scholar
• Kearsley-Fleet L, Baildam E, Beresford MW, et al. P091 Outcomes following switching from originator to biosimilar product in children and young people with JIA. Ann Rheum Dis. 2023;82(Supplement_2):285.2–285. doi:10.1093/rheumatology/kead104.132.
   Google Scholar
• Iannone C, Marelli L, Costi S, et al. Tocilizumab in juvenile idiopathic arthritis associated uveitis, a narrative review. Children (Basel). 2023;10(3):434. doi:10.3390/children10030434.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Guly C, et al. Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. Lancet Rheumatol. 2020;2(3):e135–e141. doi:10.1016/S2665-9913(20)30008-4.
   PubMedGoogle Scholar
• Li Y, Mao X, Tang X, Mao H. Efficacy and safety of anti-TNFα therapy for uveitis associated with juvenile idiopathic arthritis: a systematic review and meta-analysis. Rheumatol Ther. 2021;8(2):711–727. doi:10.1007/s40744-021-00296-x.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Klotsche J, Tappeiner C, et al. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study. Rheumatology (Oxford). 2019;58(6):975–986. doi:10.1093/rheumatology/key406.
   PubMed Web of Science ®Google Scholar
• Rypdal V, Glerup M, Songstad NT, et al. Uveitis in juvenile idiopathic arthritis: 18-year outcome in the population-based Nordic cohort study. Ophthalmology. 2021;128(4):598–608. doi:10.1016/j.ophtha.2020.08.024.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K. Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm. 2013;21(3):180–191. doi:10.3109/09273948.2013.791701.
   PubMed Web of Science ®Google Scholar
• Cann M, Ramanan AV, Crawford A, et al. Outcomes of non-infectious paediatric uveitis in the era of biologic therapy. Pediatr Rheumatol. 2018;16(1):51. doi:10.1186/s12969-018-0266-5.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143(5):840–846.e2. doi:10.1016/j.ajo.2007.01.033.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2010;117(7):1436–1441. doi:10.1016/j.ophtha.2009.12.003.
   PubMed Web of Science ®Google Scholar
• Haasnoot AMJW, Vernie LA, Rothova A, et al. Impact of juvenile idiopathic arthritis associated uveitis in early adulthood. PLoS One. 2016;11(10):e0164312. doi:10.1371/journal.pone.0164312.
   PubMed Web of Science ®Google Scholar
• Paroli MP, Speranza S, Marino M, Pirraglia MP, Pivetti-Pezzi P. Prognosis of juvenile rheumatoid arthritis-associated uveitis. Eur J Ophthalmol. 2003;13(7):616–621. doi:10.1177/112067210301300704.
   PubMed Web of Science ®Google Scholar
• Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143(4):647–655.e1. doi:10.1016/j.ajo.2006.11.025.
   PubMed Web of Science ®Google Scholar
• Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. British J Ophthalmol. 2002;86(1):51–56. doi:10.1136/bjo.86.1.51.
   PubMed Web of Science ®Google Scholar
• Zulian F, Martini G, Falcini F, et al. Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J Rheumatol. 2002;29(11):2446–2453.
   PubMed Web of Science ®Google Scholar
• Kalinina Ayuso V, ten Cate HAT, van der Does P, Rothova A, de Boer JH. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149(6):994–999.e5. doi:10.1016/j.ajo.2010.01.016.
   PubMed Web of Science ®Google Scholar
• Holland GN, Denove CS, Yu F. Chronic anterior uveitis in children: clinical characteristics and complications. Am J Ophthalmol. 2009;147(4):667–678.e5. doi:10.1016/j.ajo.2008.11.009.
   PubMed Web of Science ®Google Scholar
• Sabri K, Saurenmann RK, Silverman ED, Levin AV. Course, complications, and outcome of juvenile arthritis–related uveitis. J Aapos. 2008;12(6):539–545. doi:10.1016/j.jaapos.2008.03.007.
   PubMed Web of Science ®Google Scholar
• Chen CS, Roberton D, Hammerton ME. Juvenile arthritis-associated uveitis: visual outcomes and prognosis. Can J Ophthalmol. 2004;39(6):614–620. doi:10.1016/S0008-4182(04)80026-7.
   PubMed Web of Science ®Google Scholar
• BenEzra D, Cohen E, Behar-Cohen F. Uveitis and juvenile idiopathic arthritis: a cohort study. Clin Ophthalmol. 2007;1:513–518.
   PubMedGoogle Scholar
• Gregory AC, Kempen JH, Daniel E, et al. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study. Ophthalmology. 2013;120(1):186–192. doi:10.1016/j.ophtha.2012.07.052.
   PubMed Web of Science ®Google Scholar
• Orès R, Terrada C, Errera M-H, et al. Laser flare photometry: a useful tool for monitoring patients with juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2022;30(1):118–128. doi:10.1080/09273948.2020.1792511.
   PubMed Web of Science ®Google Scholar
• Davis JL, Dacanay LM, Holland GN, et al. Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol. 2003;135(6):763–771. doi:10.1016/S0002-9394(03)00315-5.
   PubMed Web of Science ®Google Scholar
• Sijssens KM, Rothova A, Van De Vijver DAMC, Stilma JS, De Boer JH. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;144(4):574–579.e1. doi:10.1016/j.ajo.2007.06.030.
   PubMed Web of Science ®Google Scholar
• Magli A, Forte R, Rombetto L, Alessio M. Cataract management in juvenile idiopathic arthritis: simultaneous versus secondary intraocular lens implantation. Ocul Immunol Inflamm. 2014;22(2):133–137. doi:10.3109/09273948.2013.834062.
   PubMed Web of Science ®Google Scholar
• Foster CS, Rashid S. Management of coincident cataract and uveitis. Curr Opin Ophthalmol. 2003;14(1):1–6. doi:10.1097/00055735-200302000-00001.
   PubMedGoogle Scholar
• Bohnsack BL, Freedman SF. Surgical outcomes in childhood uveitic glaucoma. Am J Ophthalmol. 2013;155(1):134–142. doi:10.1016/j.ajo.2012.07.008.
   PubMed Web of Science ®Google Scholar
• Sijssens KM, Los LI, Rothova A, et al. Long-term ocular complications in aphakic versus pseudophakic eyes of children with juvenile idiopathic arthritis-associated uveitis. British J Ophthalmol. 2010;94(9):1145–1149. doi:10.1136/bjo.2009.167379.
   PubMed Web of Science ®Google Scholar
• Yangzes S, Seth N, Singh R, et al. Long-term outcomes of cataract surgery in children with uveitis. Indian, J Ophthalmol. 2019;67(4):490–495. doi:10.4103/ijo.IJO_846_18.
   PubMed Web of Science ®Google Scholar
• Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol. 2014;158(4):676–692.e7. doi:10.1016/j.ajo.2014.06.018.
   PubMed Web of Science ®Google Scholar
• Sijssens KM, Rothova A, Berendschot TTJM, de Boer JH. Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology. 2006;113(5):853–859.e2. doi:10.1016/j.ophtha.2006.01.043.
   PubMed Web of Science ®Google Scholar
• Kouwenberg CV, Wennink RAW, Shahabi M, et al. Clinical course and outcome in pediatric idiopathic chronic anterior uveitis. Am J Ophthalmol. 2022;241:198–205. doi:10.1016/j.ajo.2022.04.015.
   PubMed Web of Science ®Google Scholar
• Kaur S, Kaushik S, Singh Pandav S. Pediatric uveitic glaucoma. J Curr Glaucoma Pract. 2013;7(3):115–117. doi:10.5005/jp-journals-10008-1147.
   PubMedGoogle Scholar
• van Meerwijk CLLI, Wieringa WG, de Boer JH, Jansonius NM, Los LI. Factors associated with glaucoma surgery in pediatric non-infectious uveitis. Ocul Immunol Inflamm. 2023;1–6. doi:10.1080/09273948.2023.2166849.
   PubMed Web of Science ®Google Scholar
• Flemmons MS, Hsiao Y-C, Dzau J, et al. Icare rebound tonometry in children with known and suspected glaucoma. J Aapos. 2011;15(2):153–157. doi:10.1016/j.jaapos.2010.11.022.
   PubMed Web of Science ®Google Scholar
• Gautam Seth N, Yangzes S, Thattaruthody F, Singh R, Bansal R, Raj S, Kaushik S, Gupta V, Pandav SS, Ram J, Gupta A. Glaucoma secondary to uveitis in children in a tertiary care referral center. Ocul Immunol Inflamm. 2019;27(3):456–464. doi:10.1080/09273948.2017.1411517. Epub 2018 Feb 2. PMID: 29394120.
   PubMed Web of Science ®Google Scholar
• Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza-Seres M, Stephen Foster C. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213(5):300–304. doi:10.1159/000027443.
   PubMed Web of Science ®Google Scholar
• Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A. Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm. 2009;17(4):243–248. doi:10.1080/09273940902913035.
   PubMed Web of Science ®Google Scholar
• Iannucci V, Manni P, Mecarelli G, et al. Childhood uveitic glaucoma: complex management in a fragile population. Applied Sciences. 2023;13(4):2205. doi:10.3390/app13042205.
   Google Scholar
• Meerwijk CLLIV, Edema AB, Rijn LJV, Los LI, Jansonius NM. Goniotomy for non-infectious uveitic glaucoma in children. J Clin Med. 2023;12(6):2200. doi:10.3390/jcm12062200.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang W, Huang W, Chen S. A nonrandomized controlled study of inflammatory response between uveitic glaucoma and other refractory glaucoma following Ahmed glaucoma valve implantation. Zhonghua Shiyan Yanke Zazhi/Chin J Exp Ophthalmol. 2015;33:241–245.
   Google Scholar
• Kalinina Ayuso V, Scheerlinck LM, de Boer JH. The effect of an Ahmed glaucoma valve implant on corneal endothelial cell density in children with glaucoma secondary to uveitis. Am J Ophthalmol. 2013;155(3):530–535. doi:10.1016/j.ajo.2012.09.001.
   PubMed Web of Science ®Google Scholar
• Wiese K, Heiligenhaus A, Heinz C. Trabekulektomie bei juveniler idiopathischer Arthritis-assoziierter Uveitis: Langzeitergebnisse beim kindlichen Sekundärglaukom. Ophthalmologe. 2014;111(4):330–338. doi:10.1007/s00347-013-2888-9.
   PubMedGoogle Scholar
• Heinz C, Koch JM, Heiligenhaus A. Transscleral diode laser cyclophotocoagulation as primary surgical treatment for secondary glaucoma in juvenile idiopathic arthritis: high failure rate after short term follow up. Br J Ophthalmol. 2006;90(6):737–740. Preprint at doi:10.1136/bjo.2005.085936.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I. Pediatric uveitis. J Ophthalmic Vis Res. 2011;6:259–269.
   PubMedGoogle Scholar
• Ferrara M, Eggenschwiler L, Stephenson A, et al. The challenge of pediatric uveitis: tertiary referral center experience in the United States. Ocul Immunol Inflamm. 2019;27(3):410–417. doi:10.1080/09273948.2017.1420202.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Klotsche J, Niewerth M, et al. Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany. Arthritis Res Ther. 2020;22(1):81. doi:10.1186/s13075-020-02166-3.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Minden K, Tappeiner C, et al. Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Semin Arthritis Rheum. 2019;49(1):43–55. doi:10.1016/j.semarthrit.2018.11.004.
   PubMed Web of Science ®Google Scholar
• Angeles‐Han ST, Lo MS, Henderson LA, et al. Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis–associated and idiopathic chronic anterior uveitis. Arthritis Care Res (Hoboken). 2019;71(4):482–491. doi:10.1002/acr.23610.
   PubMed Web of Science ®Google Scholar
• Foeldvari I, Maccora I, Petrushkin H, et al. New and updated recommendations for the treatment of juvenile idiopathic arthritis–associated uveitis and idiopathic chronic anterior uveitis. Arthritis Care Res (Hoboken). 2023;75(5):975–982. doi:10.1002/acr.24963.
   PubMed Web of Science ®Google Scholar
• Solebo AL, Rahi JS, Dick AD, et al. Areas of agreement in the management of childhood non-infectious chronic anterior uveitis in the UK. British J Ophthalmol. 2020;104(1):11–16. doi:10.1136/bjophthalmol-2018-313789.
   PubMed Web of Science ®Google Scholar
• Haasnoot A-MJW, Kuiper JJW, Hiddingh S, et al. Ocular fluid analysis in children reveals interleukin-29/Interferon-λ1 as a biomarker for juvenile idiopathic arthritis–associated uveitis. Arthritis Rheumatol. 2016;68(7):1769–1779. doi:10.1002/art.39621.
   PubMed Web of Science ®Google Scholar
• Kalinina Ayuso V, de Boer JH, Byers HL, et al. Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis. Invest Ophthalmol Vis Sci. 2013;54(5):3709–3720. doi:10.1167/iovs.12-10865.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Yeh S, Patel P, et al. Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study. J Ophthalmic Inflamm Infect. 2018;8(1):17. doi:10.1186/s12348-018-0156-5.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376(17):1637–1646. doi:10.1056/NEJMoa1614160.
   PubMed Web of Science ®Google Scholar